Search

Harter Secrest & Emery Advises Athenex, Inc. in Connection with $30 Million Public Offering

Harter Secrest & Emery LLP, a full-service business law firm with offices throughout New York, recently represented Athenex, Inc. (Nasdaq: ATNX) in a $30 million underwritten public offering of shares of common stock and warrants. The offering closed on August 15, 2022, and the HSE Securities and Capital Markets team for the transaction included Alexander R. McClean, Margaret K. Rhoda, and Scott B. Mosley. SVB Securities LLC acted as sole book-running manager for the offering.

Founded in 2003 in Buffalo, NY, Athenex, Inc. is a global clinical-stage biopharmaceutical company dedicated to becoming a leader in the discovery, development, and commercialization of next generation cell therapy drugs for the treatment of cancer. In pursuit of this mission, Athenex, Inc. leverages years of experience in research and development, clinical trials, regulatory standards, and manufacturing. The company’s current clinical pipeline is derived mainly from the following core technologies: (1) Cell therapy, based on NKT cells and (2) Orascovery, based on a P-glycoprotein inhibitor. Athenex, Inc.’s employees worldwide are dedicated to improving the lives of cancer patients by creating more active, accessible, and tolerable treatments.

Harter Secrest & Emery is recognized as a leader in the securities and capital markets industry. With 10 attorneys devoted to practicing securities and capital markets law in Western New York, the firm brings a depth and breadth of experience unmatched in the region. Harter Secrest & Emery has represented issuers and underwriters in over 60 public offerings, with clients ranging from businesses seeking start-up capital to Fortune 500 companies. The firm’s securities practitioners assist clients with private and public offerings of securities, ongoing regulatory compliance and reporting, proxy solicitations, tender offers, digital assets and disruptive technologies, and securities litigation and arbitration before the Securities and Exchange Commission, NYSE, Nasdaq, FINRA, and state and federal courts.

Attorney Advertising. Prior results do not guarantee a similar outcome. This publication is provided as a service to clients and friends of Harter Secrest & Emery LLP. It is intended for general information purposes only and should not be considered as legal advice. The contents are neither an exhaustive discussion nor do they purport to cover all developments in the area. The reader should consult with legal counsel to determine how applicable laws relate to specific situations. ©2022 Harter Secrest & Emery LLP